Potentiometric Biosensor Based on Artificial Antibodies for an Alzheimer Biomarker Detection
This paper presents a potentiometric biosensor for the detection of amyloid β-42 (Aβ-42) in point-of-care analysis. This approach is based on the molecular imprint polymer (MIP) technique, which uses covalently immobilised Aβ-42 to create specific detection cavities on the surface of single-walled c...
Main Authors: | Fernandes, R. (Author), Moreira, F.T.C (Author), Ribeiro, S.C (Author), Sales, M.G.F (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
by: Xi-chen Zhu, et al.
Published: (2020-09-01) -
Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
by: Rosha Babapour Mofrad, et al.
Published: (2019-12-01) -
Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1‐42 in Alzheimer's Disease Neuroimaging Initiative participants
by: Wei Li, et al.
Published: (2018-01-01) -
Potentiometric Urea Biosensor Based on an Immobilised Fullerene-Urease Bio-Conjugate
by: Kasra Saeedfar, et al.
Published: (2013-12-01) -
Low-dose ionizing radiation alleviates Aβ42-induced cell death via regulating AKT and p38 pathways in Drosophila Alzheimer's disease models
by: Soojin Hwang, et al.
Published: (2019-02-01)